特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
920148

ヒト成長ホルモンの世界市場:用途、投与経路、流通チャネル別 - 機会分析、および産業予測(2019年~2026年)

Human Growth Hormone Market by Application, Route of Administration, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026

出版日: | 発行: Allied Market Research | ページ情報: 英文 212 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
ヒト成長ホルモンの世界市場:用途、投与経路、流通チャネル別 - 機会分析、および産業予測(2019年~2026年)
出版日: 2019年11月13日
発行: Allied Market Research
ページ情報: 英文 212 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒト成長ホルモン市場は、2018年に28億4,070万米ドルとなりました。同市場は、2019年から2026年の間に8.6%のCAGRで成長する見通しで、2026年には55億6,360万米ドルに達すると予測されています。

当レポートは世界のヒト成長ホルモン市場について調査しており、市場機会、成長および阻害要因、用途・投与経路・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • レポートの説明
  • 利害関係者の主な利点
  • 調査方法
    • 二次調査
    • 一次調査
    • アナリストのツール・モデル

第2章 エグゼクティブサマリー

  • Cxoの見解

第3章 市場の概要

  • 市場の定義・範囲
  • ポーターのファイブフォース分析
  • 主要企業の位置づけ
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会

第4章 市場分析:用途別

  • 概要
    • 市場規模・予測
  • 成長ホルモン欠乏症
    • 主要市場の動向・機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • プラダー・ウィリー症候群
  • ターナー症候群
  • 在胎不当過小児(Sga)
  • その他

第5章 市場分析:投与経路別

  • 概要
    • 市場規模・予測
  • 経口
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 静脈内
  • 筋肉内
  • 皮下

第6章 市場分析:流通チャネル別

  • 概要
    • 市場規模・予測
  • 病院薬局
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 小売薬局
  • オンライン薬局

第7章 市場分析:地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主要市場の動向・機会
    • 用途別
    • 投与経路別
    • 流通チャネル
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ

第8章 企業プロファイル

  • Novo Nordisk
    • 企業概要
    • 企業スナップショット
    • 事業セグメント
    • 製品ポートフォリオ
    • 業績
  • Merck & Co.
  • Eli Lilly And Company.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries.
  • Novartis Ag
  • Anhui Anke Biotechnology (Group) Co., Ltd.
  • Roche
  • Ipsen
  • Ferring Bv
図表

List of Tables

List of Tables

Table 01. Global Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 02. Growth Hormone Deficiency Market, By Region, 2018-2026 ($Million)

Table 03. Comparative Share Analysis of Human Growth Hormone Market For Growth Hormone Deficiency, By Country, 2018 & 2026 (%)

Table 04. Prader-Willi Syndrome Market By Region 2018-2026 ($Million)

Table 05. Comparative Share Analysis of Human Growth Hormone Market For Prader Willi, By Country, 2018 & 2026 (%)

Table 06. Turner Syndrome Market By Region 2018-2026 ($Million)

Table 07. Comparative Share Analysis of Human Growth Hormone Market For Turner Syndrome, By Country, 2018 & 2026 (%)

Table 08. Human Growth Hormone Market For Small For Gestational Age (Sga) Market By Region 2018-2026 ($Million)

Table 09. Comparative Share Analysis of Human Growth Hormone Market For Sgh, By Country, 2018 & 2026 (%)

Table 10. Human Growth Hormone Market For Other Applications By Region 2018-2026 ($Million)

Table 11. Comparative Share Analysis of Human Growth Hormone Market For Other Applications, By Country, 2018 & 2026 (%)

Table 12. Global Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 13. Oral Route of Adminstration By Region, 2018-2026 ($Million)

Table 14. Comparative Share Analysis of Human Growth Hormone Market For Oral, By Country, 2018 & 2026 (%)

Table 15. Intravenous Route of Administration Market By Region 2018-2026 ($Million)

Table 16. Comparative Share Analysis of Human Growth Hormone Market For Intravenous, By Country, 2018 & 2026 (%)

Table 17. Intramuscular Route of Administration Market By Region 2018-2026 ($Million)

Table 18. Comparative Share Analysis of Human Growth Hormone Market For Intramuscular, By Country, 2018 & 2026 (%)

Table 19. Subcutaneous Route of Administration Market By Region 2018-2026 ($Million)

Table 20. Comparative Share Analysis of Human Growth Hormone Market For Subcutaneous, By Country, 2018 & 2026 (%)

Table 21. Global Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 22. Hospital Pharmacy Human Growth Hormone Market, By Region, 2018-2026 ($Million)

Table 23. Retail Pharmacy Human Growth Hormone Market, By Region, 2018-2026 ($Million)

Table 24. Online Pharmacy Human Growth Hormone Market, By Region, 2018-2026 ($Million)

Table 25. Human Growth Hormone Market, By Region, 2018-2026 ($Million)

Table 26. North America Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 27. North America Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 28. North America Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 29. U.S. Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 30. U.S. Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 31. U.S. Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 32. Canada Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 33. Canada Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 34. Canada Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 35. Mexico Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 36. Mexico Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 37. Mexico Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 38. Europe Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 39. Europe Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 40. Europe Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 41. Europe Human Growth Hormone Market, By Country, 2018-2026 ($Million)

Table 42. France Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 43. France Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 44. France Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 45. Uk Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 46. Uk Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 47. Uk Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 48. Germany Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 49. Germany Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 50. Germany Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 51. Spain Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 52. Spain Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 53. Spain Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 54. Rest of Europe Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 55. Rest of Europe Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 56. Rest of Europe Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 57. Asia-Pacific Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 58. Asia-Pacific Human Growth Hormone Market, By Administration, 2018-2026 ($Million)

Table 59. Asia-Pacific Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 60. Asia-Pacific Human Growth Hormone Market, By Country, 2018-2026 ($Million)

Table 61. Japan Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 62. Japan Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 63. Japan Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 64. China Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 65. China Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 66. China Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 67. India Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 68. India Human Growth Hormone Market, By Administration, 2018-2026 ($Million)

Table 69. India Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 70. Australia Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 71. Australia Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 72. Australia Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 73. Rest of Asia-Pacific Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 74. Rest of Asia-Pacific Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 75. Rest of Asia-Pacific Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 76. Lamea Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 77. Lamea Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 78. Lamea Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 79. Lamea Human Growth Hormone Market, By Country, 2018-2026 ($Million)

Table 80. Brazil Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 81. Brazil Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 82. Brazil Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 83. Saudi Arabia Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 84. Saudi Arabia Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 85. Saudi Arabia Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 86. South Africa Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 87. South Africa Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 88. South Africa Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 89. Rest of Lamea Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 90. Rest of Lamea Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 91. Rest of Lamea Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 92. Novo Nordisk: Company Snapshot

Table 93. Novo Nordisk: Operating Segments

Table 94. Novo Nordisk Plc: Product Portfolio

Table 95. Merck & Co.: Company Snapshot

Table 96. Merck & Co. Inc.: Operating Segments

Table 97. Merck & Co. Inc.: Product Portfolio

Table 98. Eli Lilly And Company.: Company Snapshot

Table 99. Eli Lilly And Company.: Operating Segments

Table 100. Eli Lilly And Company.: Product Portfolio:

  • Table 101. Pfizer Inc.: Company Snapshot
  • Table 102. Pfizer Inc.: Operating Segments
  • Table 103. Pfizer Inc.: Product Portfolio
  • Table 104. Teva Pharmaceutical Industries.: Company Snapshot
  • Table 105. Teva Pharmaceutical Industries.: Operating Segments
  • Table 106. Teva Pharmaceutical Industries.: Product Portfolio
  • Table 107. Novartis Ag: Company Snapshot
  • Table 108. Novartis Ag: Operating Segments
  • Table 109. Novartis Ag: Product Portfolio
  • Table 110. Anhui Anke Biotechnology (Group) Co., Ltd.: Company Snapshot
  • Table 111. Anhui Anke Biotechnology (Group) Co., Ltd.: Operating Segments
  • Table 112. Anhui Anke Biotechnology (Group) Co., Ltd: Product Portfolio
  • Table 113. Roche: Company Snapshot
  • Table 114. Roche: Operating Segments
  • Table 115. Roche: Product Portfolio
  • Table 116. Ipsen: Company Snapshot
  • Table 117. Ipsen: Product Segments
  • Table 118. Ipsen: Product Portfolio
  • Table 119. Ferring Bv.: Company Snapshot
  • Table 120. Ferring Bv.: Operating Segments
  • Table 121. Ferring Bv: Product Portfolio

List of Figures

List of Figures

Figure 01. Global Human Growth Hormone Market Segmentation

Figure 02. Low-To- Moderate Bargaining Power of Supplier

Figure 03. Moderate Bargaining Power of Buyer

Figure 04. Moderate Threat of Substitutes

Figure 05. Low-To-Moderate Threat of New Entrants

Figure 06. Low Competitive Rivalary

Figure 07. Top Player Positioning, 2018

Figure 08. Drivers And Restraints

Figure 09. Comparative Share Analysis of Human Growth Hormone Market, For Hospitals, By Country, 2018 & 2026 (%)

Figure 10. Comparative Share Analysis of Human Growth Hormone Market For Retail Pharmacy, By Country, 2018 & 2026 (%)

Figure 11. Comparative Share Analysis of Human Growth Hormone Market For Online Pharmacy, By Country, 2018 & 2026 (%)

Figure 12. Novo Nordisk: Revenue Share By Segment, 2018 (%)

Figure 13. Novo Nordisk: Revenue Share By Geography, 2018 (%)

Figure 14. Merck & Co.: Net Sales, 2016-2018 ($Million)

Figure 15. Merck & Co.: Revenue Share By Segment, 2018 (%)

Figure 16. Merck & Co.: Revenue Share By Region, 2018(%)

Figure 17. Eli Lilly And Company: Net Sales, 2016-2018 ($Million)

Figure 18. Eli Lilly And Company: Revenue Share By Region, 2018(%)

Figure 19. Eli Lilly And Company: Revenue Share By Segment, 2018 (%)

Figure 20. Pfizer: Net Sales, 2016-2018 ($Million)

Figure 21. Pfizer.: Revenue Share By Segment, 2018 (%)

Figure 01. Pfizer Inc: Revenue Share By Region, 2018(%)

Figure 02. Teva Pharmaceutical Industries.: Net Sales, 2016-2018 ($Million)

Figure 03. Teva Pharmaceutical Industries.: Revenue Share By Regions, 2018 (%)

Figure 04. Novartis Ag: Net Sales, 2016-2018 ($Million)

Figure 05. Novartis Ag: Revenue Share By Region, 2018(%)

Figure 06. Novartis Ag: Revenue Share By Segment, 2018 (%)

Figure 07. Roche: Net Sales, 2016-2018 ($Million)

Figure 08. Roche: Revenue Share By Segment, 2018 (%)

Figure 09. Roche: Revenue Share By Geography, 2018 (%)

Figure 10. Ipsen: Net Sales, 2016-2018 ($Million)

Figure 11. Ipsen: Revenue Share By Segment, 2018 (%)

Figure 12. Ipsen: Revenue Share By Geography, 2018 (%)

Figure 13. Ferring Bv.: Net Sales, 2016-2018 ($Million)

Figure 14. Ferring Bv.: Revenue Share By Region, 2018(%)

Figure 15. Roche: Revenue Share By Segment, 2018 (%)

目次
Product Code: LI_195557

The global human growth hormone market was valued at $2,840.70 million in 2018 and is expected to reach $5,563.60 million by 2026, registering a CAGR of 8.6% from 2019 to 2026. Human growth hormone is a protein made by the pituitary gland and is secreted into the bloodstream to other parts of the body. Its production is regulated by an intricate set of hormones produced in the hypothalamus gland, intestinal tract, and pancreas. Further, these hormones act on several tissues throughout the body. In adolescents, it stimulates the growth of bone and cartilage. Whereas in adults, it boosts protein production, promotes the utilization of fat, interferes with the action of insulin, and raises blood sugar levels. GH also raises levels of insulin-like growth factor1.

Surge in awareness regarding the effectiveness of growth hormones and increase in prevalence of chronic diseases including growth retardation and pituitary dysfunctions and surge in compliance for growth hormone formulations are the major factors that drive the growth of the global human growth hormone market. However, the side effects associated with its vigorous usage such as muscle pain, joint pain, and fluid retention and high cost of the treatment hampers the growth of the market. Moreover, stringent government approvals are expected to restrain the growth and development of the market in the coming years. Furthermore, rise in disposable income and surge in healthcare expenditure in developing economies is anticipated to create lucrative growth opportunities for the market.

The human growth hormone market can be segmented on the basis of application, route of administration, distribution channel, and region. By application, it is categorized into growth hormone deficiency, Prader-Willi syndrome, Turner syndrome, and small for gestational age, and others . By route of administration, it is classified into intravenous, intramuscular, subcutaneous, and oral. On the basis of distribution channel, it is divided into hospital pharmacy, retail pharmacy, clinic, and online pharmacy. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Application

  • Growth Hormone Deficiency
  • Prader-Willi Syndrome
  • Turner Syndrome
  • Small for Gestational Age
  • Others

By Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Pharmacy

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS
  • Novo Nordisk
  • Merck & Co., Inc
  • Eli Lilly and Company
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • AnkeBio Co. Ltd
  • F. Hoffmann-La Roche
  • Ipsen
  • Ferring B.V.

Table of Contents

Chapter 1: Introduction

  • 1.1. Report Description
  • 1.2. Key Benefits For Stakeholders
  • 1.3. Research Methodology
    • 1.3.1. Secondary Research
    • 1.3.2. Primary Research
    • 1.3.3. Analyst Tools & Models

Chapter 2: Executive Summary

  • 2.1. Cxo Perspective

Chapter 3: Market Overview

  • 3.1. Market Definition And Scope
  • 3.2. Porter'S Five Forces Analysis
  • 3.3. Top Player Positioning
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase In Usage Of Growth Hormone To Control Aging
      • 3.4.1.2. Surge In Disorders Related To Growth Hormone Deficiency
    • 3.4.2. Restraints
      • 3.4.2.1. Side Effects Associated With The Treatment
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise In Awareness Towards Usage Of Human Growth In Developing Economies

Chapter 4: Human Growth Hormone Market, By Application

  • 4.1. Overview
    • 4.1.1. Market Size And Forecast, By Application
  • 4.2. Growth Hormone Deficiency
    • 4.2.1. Key Market Trends And Opportunities
    • 4.2.2. Market Size And Forecast, By Region
    • 4.2.3. Market Analysis, By Country
  • 4.3. Prader-Willi Syndrome
    • 4.3.1. Key Market Trends And Opportunities
    • 4.3.2. Market Size And Forecast, By Region
    • 4.3.3. Market Analysis, By Country
  • 4.4. Turner Syndrome
    • 4.4.1. Key Market Trends And Opportunities
    • 4.4.2. Market Size And Forecast, By Region
    • 4.4.3. Market Analysis, By Country
  • 4.5. Small For Gestational Age (Sga)
    • 4.5.1. Key Market Trends And Opportunities
    • 4.5.2. Market Size And Forecast, By Region
    • 4.5.3. Market Analysis, By Country
  • 4.6. Others
    • 4.6.1. Key Market Trends And Opportunities
    • 4.6.2. Market Size And Forecast, By Region
    • 4.6.3. Market Analysis, By Country

Chapter 5: Human Growth Hormone Market, By Route Of Administration

  • 5.1. Overview
    • 5.1.1. Market Size And Forecast, By Application
  • 5.2. Oral
    • 5.2.1. Market Size And Forecast, By Region
    • 5.2.2. Market Analysis, By Country
  • 5.3. Intravenous
    • 5.3.1. Market Size And Forecast, By Region
    • 5.3.2. Market Analysis, By Country
  • 5.4. Intramuscular
    • 5.4.1. Market Size And Forecast, By Region
    • 5.4.2. Market Analysis, By Country
  • 5.5. Subcutaneous
    • 5.5.1. Market Size And Forecast, By Region
    • 5.5.2. Market Analysis, By Country

Chapter 6: Human Growth Hormone Market, Distribution Channel

  • 6.1. Overview
    • 6.1.1. Market Size And Forecast, Distribution Channel
  • 6.2. Hospital Pharmacy
    • 6.2.1. Market Size And Forecast, By Region
    • 6.2.2. Market Analysis, By Country
  • 6.3. Retail Pharmacy
    • 6.3.1. Market Size And Forecast, By Region
    • 6.3.2. Market Analysis, By Country
  • 6.4. Online Pharmacy
    • 6.4.1. Market Size And Forecast, By Region
    • 6.4.2. Market Analysis, By Country

Chapter 7: Human Growth Hormone Market, By Region

  • 7.1. Overview
    • 7.1.1. Market Size And Forecast
  • 7.2. North America
    • 7.2.1. Key Market Trends And Opportunities
    • 7.2.2. Market Size And Forecast, By Application
    • 7.2.3. Market Size And Forecast, By Route Of Administration
    • 7.2.4. Market Size And Forecast, Distribution Channel
      • 7.2.4.1. U.S. Market Size And Forecast, By Application
      • 7.2.4.2. U.S. Market Size And Forecast, By Route Of Administration
      • 7.2.4.3. U.S. Market Size And Forecast, Distribution Channel
      • 7.2.4.4. Canada Market Size And Forecast, By Application
      • 7.2.4.5. Canada Market Size And Forecast, By Route Of Administration
      • 7.2.4.6. Canada Market Size And Forecast, Distribution Channel
      • 7.2.4.7. Mexico Market Size And Forecast, By Application
      • 7.2.4.8. Mexico Market Size And Forecast, By Route Of Administration
      • 7.2.4.9. Mexico Market Size And Forecast, Distribution Channel
  • 7.3. Europe
    • 7.3.1. Key Market Trends And Opportunities
    • 7.3.2. Europe Market Size And Forecast, By Application
    • 7.3.3. Europe Market Size And Forecast, By Route Of Administration
    • 7.3.4. Europe Market Size And Forecast, Distribution Channel
    • 7.3.5. Europe Market Size And Forecast, By Country
      • 7.3.5.1. France Market Size And Forecast, By Application
      • 7.3.5.2. France Market Size And Forecast, By Route Of Administration
      • 7.3.5.3. France Market Size And Forecast, Distribution Channel
      • 7.3.5.4. Uk Market Size And Forecast, By Application
      • 7.3.5.5. Uk Market Size And Forecast, By Route Of Administration
      • 7.3.5.6. Uk Market Size And Forecast, Distribution Channel
      • 7.3.5.7. Germany Market Size And Forecast, By Application
      • 7.3.5.8. Germany Market Size And Forecast, By Route Of Administration
      • 7.3.5.9. Germany Market Size And Forecast, Distribution Channel
      • 7.3.5.10. Spain Market Size And Forecast, By Application
      • 7.3.5.11. Spain Market Size And Forecast, By Route Of Administration
      • 7.3.5.12. Spain Market Size And Forecast, Distribution Channel
      • 7.3.5.13. Rest Of Europe Market Size And Forecast, By Application
      • 7.3.5.14. Rest Of Europe Market Size And Forecast, By Route Of Administration
      • 7.3.5.15. Rest Of Europe Market Size And Forecast, Distribution Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends And Opportunities
    • 7.4.2. Asia-Pacific Market Size And Forecast, By Application
    • 7.4.3. Asia-Pacific Market Size And Forecast, By Route Of Administration
    • 7.4.4. Asia-Pacific Market Size And Forecast, Distribution Channel
    • 7.4.5. Asia-Pacific Market Size And Forecast, By Country
      • 7.4.5.1. Japan Market Size And Forecast, By Application
      • 7.4.5.2. Japan Market Size And Forecast, By Route Of Administration
      • 7.4.5.3. Japan Market Size And Forecast, Distribution Channel
      • 7.4.5.4. China Market Size And Forecast, By Application
      • 7.4.5.5. China Market Size And Forecast, By Route Of Administration
      • 7.4.5.6. China Market Size And Forecast, Distribution Channel
      • 7.4.5.7. India Market Size And Forecast, By Application
      • 7.4.5.8. India Market Size And Forecast, By Route Of Administration
      • 7.4.5.9. India Market Size And Forecast, Distribution Channel
      • 7.4.5.10. Australia Market Size And Forecast, By Application
      • 7.4.5.11. Australia Market Size And Forecast, By Application
      • 7.4.5.12. Australia Market Size And Forecast, Distribution Channel
      • 7.4.5.13. Rest Of Asia-Pacific Market Size And Forecast, By Application
      • 7.4.5.14. Rest Of Asia-Pacific Market Size And Forecast, By Route Of Administration
      • 7.4.5.15. Rest Of Asia-Pacific Market Size And Forecast, Distribution Channel
  • 7.5. Lamea
    • 7.5.1. Key Market Trends And Opportunities
    • 7.5.2. Lamea Market Size And Forecast, By Application
    • 7.5.3. Lamea Market Size And Forecast, By Route Of Administration
    • 7.5.4. Lamea Market Size And Forecast, Distribution Channel
    • 7.5.5. Lamea Market Size And Forecast, By Country
      • 7.5.5.1. Brazil Market Size And Forecast, By Application
      • 7.5.5.2. Brazil Market Size And Forecast, By Route Of Administration
      • 7.5.5.3. Brazil Market Size And Forecast, Distribution Channel
      • 7.5.5.4. Saudi Arabia Market Size And Forecast, By Application
      • 7.5.5.5. Saudi Arabia Market Size And Forecast, By Route Of Administration
      • 7.5.5.6. Saudi Arabia Market Size And Forecast, Distribution Channel
      • 7.5.5.7. South Africa Market Size And Forecast, By Application
      • 7.5.5.8. South Africa Market Size And Forecast, By Route Of Administration
      • 7.5.5.9. South Africa Market Size And Forecast, Distribution Channel
      • 7.5.5.11. Rest Of Lamea Market Size And Forecast, By Application
      • 7.5.5.12. Rest Of Lamea Market Size And Forecast, By Route Of Administration
      • 7.5.5.13. Rest Of Lamea Market Size And Forecast, Distribution Channel

Chapter 8: Company Profiles

  • 8.1. Novo Nordisk
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Operating Business Segments
    • 8.1.4. Product Portfolio
    • 8.1.5. Business Performance
  • 8.2. Merck & Co.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Operating Business Segments
    • 8.2.4. Product Portfolio
    • 8.2.5. Business Performance
  • 8.3. Eli Lilly And Company.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Operating Business Segments
    • 8.3.4. Product Portfolio
    • 8.3.5. Business Performance
  • 8.4. Pfizer Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Operating Business Segments
    • 8.4.4. Product Portfolio
    • 8.4.5. Business Performance
  • 8.5. Teva Pharmaceutical Industries.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Operating Business Segments
    • 8.5.4. Product Portfolio
    • 8.5.5. Business Performance
  • 8.6. Novartis Ag
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Operating Business Segments
    • 8.6.4. Product Portfolio
    • 8.6.5. Business Performance
  • 8.7. Anhui Anke Biotechnology (Group) Co., Ltd.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Operating Business Segments
    • 8.7.4. Product Portfolio
  • 8.8. Roche
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Operating Business Segments
    • 8.8.4. Product Portfolio
    • 8.8.5. Business Performance
  • 8.9. Ipsen
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Operating Business Segments
    • 8.9.4. Product Portfolio
    • 8.9.5. Business Performance
  • 8.10. Ferring Bv
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Operating Business Segments
    • 8.10.4. Product Portfolio
    • 8.10.5. Business Performance
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.